Authors' Reply - Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?
Clinics
; Clinics;74: e1517, 2019.
Article
in En
| LILACS
| ID: biblio-1039551
Responsible library:
BR1.1
Full text:
1
Index:
LILACS
Main subject:
Crohn Disease
Limits:
Humans
Country/Region as subject:
America do sul
/
Brasil
Language:
En
Journal:
Clinics
Journal subject:
MEDICINA
Year:
2019
Type:
Article